Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has acquired 26% of the paid up equity share capital of O2 Renewable Energy IX (SPV) in the first tranche, in accordance with terms and conditions of the Security Subscription and Shareholders’ Agreement (SSHA). The object of acquisition is to access renewable power through solar and wind power plants through (Inter-State Transmission System) ISTS under captive structure. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.